Skip to content
  • Home
  • Medical Supplies
  • Medical Insurance
  • Healthy Lifestyle
  • Medical Treatment
  • Healthy Diet
  • Healthy Parenting
  • About Us
cdnaas

cdnaas

everything health

Feds require health plans to report drug costs under new rule

Posted on November 23, 2021 By Sharika Soukup

Payers, employers and other group health plan sponsors must report prescription drug and health coverage costs for consumers under a federal regulation published Wednesday.

Plans and issuers must begin reporting information by Dec. 27, 2021 and submit their information each following year by June 1. However, the rule says enforcement actions won’t be taken against plans or issuers that submit their 2020 and 2021 information by Dec. 27, 2022.

The interim final rule is the fourth regulation to date implementing the No Surprises Act. The Health and Human Services Department, Labor Department, Treasury Department and Office of Personnel Management promulgated the regulation.

“Life-saving prescription drugs should not cost anyone their life savings,” HHS Secretary Xavier Becerra said in a news release. “Today the Biden-Harris Administration is taking additional steps to make healthcare more accessible and affordable for patients. By collecting key data on the costs of prescription drugs, we are promoting competition and transparency in the healthcare industry as we continue to curb the rising costs of drugs and surprise medical bills.”

In addition to general information on their enrollment and total health spending, payers and issuers on the individual markets will have to submit prescription drug spending information to each of the federal departments implementing the rule, including average monthly premiums paid by employees compared to employers.

Plans and issuers will also need to report the 50 most frequently dispensed brand prescription drugs, the 50 costliest prescription drugs by total annual spending and the 50 prescription drugs with the greatest increase in plan or coverage spending from the prior year. Prescription drug rebates and fees paid to the plan or issuer by manufacturers in each class of therapeutics will need to be reported as well, along with the impact of these rebates and fees on premiums and out-of-pocket costs.

Plan sponsors, issuers and Federal Employees Health Benefits Program carriers will submit this information for the state or market level instead of separately for each plan, CMS says.

Once this information is submitted, HHS will publish a report on prescription drug pricing trends and rebates and how they impact consumer costs. The administration expects these reports, which will be updated biannually, to clarify prescription drugs’ role in increased healthcare spending and costs.

The rule notes that information will also offer insight into competition and market concentration in pharmaceutical and healthcare industries. The data can help the administration tackle high prices driven by industry concentration and other anti-competitive behaviors, which President Joe Biden pledged to fight in an executive order issued in July.

Wednesday’s prescription drug transparency policy is part of the administration’s implementation of the No Surprises Act, passed by Congress as part of last year’s end-of-year spending package. The law aims to make it so patients only have to pay in-network rates for out-of-network emergency services or air ambulance trips. Payers and providers will have 30 days to settle discrepancies and bills that remain unsettled will go through an arbitration process.

Stakeholders reacted with skepticism of the policy to outright opposition toward it, and they largely haven’t appreciated how the administration has chosen to implement the policy either. Lawmakers with medical degrees have also criticized the implementation, saying it goes against Congress’ intent for the No Surprises Act.

The first rule to implement the No Surprises Act, released in July, banned surprise medical bills for emergency services, air ambulance services and certain non-emergency services. Throughout the fall, the Biden administration released other policies laying out the process to settle disputes and requiring plans and issuers to submit information about air ambulance services and require agents to disclose compensation for enrolling people in certain health coverage.

The Association of Air Medical Services sued the federal government to block these regulations on Tuesday.

Comments on Wednesday’s interim final rule are due by Jan. 24.

https://www.modernhealthcare.com/policy/feds-require-health-plans-report-drug-coverage-costs-under-new-rule

Medical Treatment Tags:costs, drug, Feds, Health, Plans, report, require, rule

Post navigation

Previous Post: Children’s Health’s Transgender Treatment Clinic Is No More
Next Post: How can a Corporate Fruit Basket Offer Strengths at the Workplace?

More Related Articles

What Happens if You Don’t Use Long-Term Care Insurance as a Senior? Medical Treatment
Therapy or Home: How to Keep away from This Medical Final decision Medical Treatment
Diabetes Supply Business
Side Effects of Simparica Chewable Tablets for Dogs Medical Treatment
How to Choose Health Insurance: Your Step-by-Step Guide Medical Treatment
Thyroid Gland Medical Supplies

Recent Posts

  • Pediatric Crash Cart Medications
  • Living a Balanced Everyday living – The 5 Components to a Nutritious Life-style
  • Boosting Children to Become Successful Customers of Culture
  • Why Does My Well being Insurance policy Want Me To Fill Out A Type Soon after I’ve Been Hurt In An Accident?
  • Is a Vegan Diet Better For Your Hair and Pores and skin?

Archives

  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021

Copyright © 2023 cdnaas.

Powered by PressBook Green WordPress theme